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Objectives: To report a small series of fine-needle aspiration (FNA) cytology of plasmacytoid 
urothelial carcinoma (PVUC).  
Study design: A computerized search of our laboratory information system was performed for 
the 5-year period (01/2008–01/2013) to identify all FNA cases in which the corresponding 
surgical pathology cases were diagnosed as PVUC.  
Results: Four cases identified were from 2 men (ages 56 and 64) and 2 women (ages 72 and 46). 
The FNA smears demonstrated low to moderate cellularity and consisted predominantly of single 
and dyshesive, medium-sized tumor cells with eccentrically located nuclei and moderate 
abundant dense cytoplasm. The nuclei were oval with slightly irregular nuclear membranes and 
contained coarse granular chromatin with inconspicuous or small nucleoli. There was moderate 
nuclear variation in size. The nuclear to cytoplasmic ratio ranged from <1 to 3. Binucleation, 
cytoplasmic vacuoles, and perinuclear hof were occasionally seen.  
Conclusions: FNA cytology of plasmacytoid urothelial carcinoma shares similar features with 
plasma cell neoplasms, lobular carcinoma of the breast, and signet ring cell carcinoma of the 
stomach. Being aware of the patient’s clinical history and the potential diagnostic pitfall of this 
rare variant of urothelial carcinoma is important for an accurate diagnosis on FNA biopsy. 
 






The plasmacytoid variant of urothelial carcinoma (PVUC) is a rare and aggressive histologic 
variant of urothelial carcinoma. It has been recognized in the 2004 World Health Organization 
(WHO) classification of urothelial neoplasm.1 It is usually diagnosed in advanced pathological 
stage showing metastases in 60% of patients and has lower survival rate than conventional 
urothelial carcinoma (UC).2-4 Few reports on the urine cytologic findings of PVUC exist in the 
literature.5-9 However there was only one case report of fine-needle aspiration (FNA) cytologic 
findings.10 The diagnosis on FNA specimens can be challenging given its resemblance to plasma 
cells and typically without marked nuclear atypia. Recognition of this tumor is important, 
particularly at metastatic sites, since it may indicate disease recurrence typical of its aggressive 
behavior that may require a different therapeutic approach. We herein report our experiences 




A 71-year-old female presented with bilateral hydronephrosis.  She was noted to have irregular 
bladder thickening, right side greater than left on CT scan. Cystectomy revealed a tumor 
involving the uterine wall, bilateral fallopian tubes and rectum (pT4, N0, M1). Thirteen months 
after receiving 9 cycles of chemotherapy, the tumor recurred in the perineal soft tissue diagnosed 
by FNA. 
Case #2 
A 55-year-old male presented with hematuria. He underwent a transurethral resection of bladder 





(95%) that had invaded perinephric fat, seminal vesicals and prostate and involved one of 46 
regional lymph nodes (pT4, N1, Mx).  Fourteen months after receiving multiple cycles of 
chemotherapy, a new lesion was found anterior to the left psoas near the left ureter. FNA 
confirmed metastatic urothelial carcinoma.  
Case #3 
A 46-year-old female presented with hematuria and a CT scan revealed irregular bladder 
thickening. Transurethral biopsy showed high-grade carcinoma with glandular differentiation 
and signet cell morphology.  FNA of right iliac lymph node showed rare atypical cells highly 
suspicious for metastatic urothelial carcinoma. After 4 cycles of chemotherapy, the patient 
underwent radical cystectomy and showed PVUC (90%) with coexisting urothelial carcinoma in 
situ and metastasis to 2 of 25 regional lymph nodes (pT3a, N2, Mx). She was found 4 months 
later to have bone metastasis and peritoneal carcinomatosis. 
Case #4  
A 63-year-old male with hematuria and the transurethral biopsy revealed urothelial carcinoma, 
mixed micropapillary and plasmacytoid variant. The cystoprostatectomy showed tumor with 
mixed micropapillary and plasmacytoid pattern invading perivesical fat and adventitia of the left 
ureteral margin and involved 4 of 19 regional lymph nodes (pT4a, N2, Mx). Nine months after 
receiving chemotherapy, he was noted to have metastasis to left retroperitoneal lymph node that 
was diagnosed by FNA.  
 
Materials and Methods 
This study was approved by Indiana University Institutional Review Board. A computerized 





2013) to identify all FNA cases in which the corresponding surgical pathology cases were 
diagnosed as PVUC. The reports, slides and related clinical histories were retrospectively 
reviewed. The patient’s age, sex, metastatic tumor sites, tumor stage and histologic diagnoses 
were summarized in Table 1. The Papanicolaou-stained ethanol-fixed and Protol Hema 3-stained 
(Fisher Scientific, Kalamazoo, MI) air-dried direct smears from each case as well as the 
corresponding hematoxylin and eosin-stained slides from the corresponding surgical resection of 
the tumors were reviewed. Cytologic features including cellular cohesiveness, nuclear location, 
nuclear variation, chromatin, nuclear membrane, nucleoli, nucleus/cytoplasm ratio, cytoplasmic 
vacuole, perinuclear hof, binucleation and multinucleation were analyzed and tabulated (Table 
2). Case 3 was stained with CK7, CK20, Ber-EP4, MOC31, CD138, Gata 3, calretinin, and D2-
40. Additional stains p63, 34βE12, MUM1, ER and PR were retrospectively performed on the 





The FNA cytology of PVUC showed low to moderate cellularity with predominantly single and 
dyshesive, medium-sized tumor cells. There was moderate nuclear variation in size. The oval 
nuclei were eccentrically located with slightly irregular nuclear membrane and contained coarse 
granular chromatin and inconspicuous or small nucleoli. The nuclear to cytoplasmic ratio ranged 
from low to intermediate. Occasional binucleation, cytoplasmic vacuoles and perinuclear hof 
were noted (Figure 1A, 1B). In case number 4, tightly cohesive clusters of tumor cells that 





plasmacytoid tumor cells in the FNA smears of the metastatic retroperitoneal lymph nodes 
(Figure 2A). 
Immunocytochemical stains were performed on the cell block of case 3 and the tumor cells 
expressed CK20, Ber-EP4 and MOC31, and focally expressed CK7 and 34βE12, but negative for 
CD138, p63, Gata3, MUM1, ER, PR, calretinin and D2-40. The corresponding bladder tumors of 
case 3 were positive for 34βE12, while negative for p63, MUM1. ER and PR. 
Histologic Findings 
The histology of Cases 1, 2, and 3 was similar. The tumor cells were relatively uniform, 
dyshesive with moderate abundant eosinophilic to amphophilic cytoplasm and eccentrically 
located nuclei with irregular nuclear membrane and indistinct nucleoli (Figure 1C). Foci of 
carcinoma in situ and a few malignant cells of signet ring cell type were also noted. In Case 4, 
there were mixtures of tumor cells with plasmacytoid and micropapillary features. Both patterns 
were admixed intimately throughout the tumor (Figure 2B).  
 
Discussion: 
PVUC is a rare and aggressive variant of urothelial carcinoma. Patients with PVUC who 
were diagnosed with a higher stage at cystectomy were more likely to have lymph node 
involvement, and positive surgical margins than patients with conventional UC. Median overall 
survival and disease-specific survival were 19 and 22 months for PVUC, respectively, which 
were significantly worse than patients with conventional UC. Plasmacytoid variant histology was 
also associated with a 2-fold increased adjusted risk of all-cause mortality.14  
Fine needle aspiration is a popular, cost effective and safe procedure to obtain materials 





limited with  only one recently reported case of FNA findings.10 We describe herein the largest 
series of FNA cytology findings of metastatic PVUC.  The cytologic direct smears in our series 
displayed low to intermediate cellularity composed of predominately medium-sized, dyshesive 
cells with the majority of the cells containing eccentrically located oval nuclei and slightly 
irregular nuclear membrane, coarse granular chromatin and inconspicuous or small nucleoli 
(Table 2). Binucleation, cytoplasmic vacuoles, signet ring cell feature and perinuclear hof were 
seen occasionally (< 5% of the cells). The nucleus to cytoplasmic ratio was low to intermediate 
(<1 to 3). The diagnosis on FNA is challenging because most cases will have low cellularity and 
demonstrating relatively low-grade nuclear atypia.  
In our experience, pure PVUCs are rare. The majority of PVUCs will have a combination 
of conventional urothelial carcinoma, urothelial carcinoma in situ or other variant of urothelial 
carcinoma.2-3 FNA cytology of the conventional urothelial carcinoma typically demonstrate 
higher grade of nuclear atypia with marked nuclear size variation, prominent nucleoli, more 
cohesive clusters and containing frequent cercariform cells. “Cercariform” cells containing 
unipolar cytoplasmic processes with non-tapered, flattened ends, were designated as such 
because of their resemblance to the cercaria of Schistosma.12-13 In our series, components of 
conventional urothelial carcinoma were not present in the cytologic samples. 
Tumor cells of PVUC also frequently have a monocyte-like or signet ring cell-like 
morphology, and are prone to misinterpretation as other neoplasms, especially in a limited 
sample, most commonly as plasma cell neoplasm, lobular carcinoma of the breast, signet ring 
cell carcinoma of the gastrointestinal tract, melanoma or neuroendocrine tumor. The correct 
diagnosis can be rendered by careful morphologic evaluation with correlation of clinical history. 





other malignancies, the use of immunohistochemical stains may be useful to achieve an accurate 
diagnosis. There have been previous series and case reports studying the immunohistochemical 
features of PVUC, but the staining results have been variable, especially for CK7, CK20, and 
CD138.2,3 A concise panel including 34BE12, p63, MUM1, CDX2, estrogen receptor (ER), and 
progesterone receptor (PR) may aid in the distinction of PVUC from mimics. 15 In our 
experience, plasmacytoid UCs are consistently positive for 34BE12 and/or p63, while negative 
for MUM1, CDX2, ER, and PR. Lobular carcinoma of the breast is positive for ER and PR while 
negative for the rest. Plasma cell neoplasms are positive for MUM1 and negative for all others. 
Signet ring cell carcinomas of the gastrointestinal tract are positive for CDX2 and negative for 
the others. If melanoma and neuroendocrine tumors are in the differential diagnosis, markers 
such as chromogranin, synaptophysin, S100 and HMB45 should also be included. We have 
retrospectively stained this panel of immunostains on case 3. The immunostains cannot be 
retrospectively performed on other cases due to low cellularity in both direct smears and cell 
blocks. The tumor cells are positive for 34BE12 while negative for p63, MUM1, CDX2, ER, and 
PR which were demonstrated in both cell blocks of FNA and paraffin blocks of the original 
tumors in case 3. There are no specific immunohistochemical markers for the diagnosis of 
PVUC. The usually sensitive markers for diagnosis of conventional urothelial carcinoma such as 
Gata3 and p63 were negative in our case. Our case was positive for CK7 and 34BE12, which 
might be more sensitive markers in the diagnosis of metastatic PVUC. However a larger series of 
study for the application of the immunohistochemistry in the diagnosis of PVUC is needed. 
Our series includes a case (case 4) of mixed plasmacytoid and micropapillary urothelial 
carcinoma where the histology demonstrated an even mixture of both plasmacytoid and 





node showed metastatic dyshesive plasmacytoid tumor cells and cohesive groups of 
micropapillary carcinoma (Figure 2A and 2B). Both plasmacytoid and micropapillary urothelial 
carcinomas are rare, aggressive variants of urothelial carcinoma. Although urothelial carcinoma 
with combined plasmacytoid and micropapillary morphology in the same cystectomy specimens 
has been reported, our case is interesting in that both plasmacytoid and micropapillary 
components were also present in both primary and metastatic sites.11 
FNA cytology of plasmacytoid urothelial carcinoma shares similar features with other 
neoplasms with plasmacytoid morphology. Being aware of the patient’s clinical history and the 
potential diagnostic pitfall of this rare variant of urothelial carcinoma is important for an accurate 
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Figure Legends  
Figure 1. A, B) FNA cytology of plasmacytoid urothelial carcinoma: Single or loose aggregate 
of medium-sized tumor cells demonstrate a plasmacytoid appearance (A, Diff Quik, x600; B, 
Papanicolaou, x600). C) Histologic section of plasmacytoid urothelial carcinoma. Plasmacytoid 
tumor cells arrange in a single file pattern with rare signet ring cell morphology (H&E, x400). 
Figure 2. A) FNA cytology of mixed plasmacytoid and micropapillary urothelial carcinoma: 
cohesive clusters of micropapillary carcinoma components noted with single plasmacytoid tumor 
cells in the background. (Papanicolaou, x400). B) Histology of mixed plasmacytoid and 





Table 1. Clinical information  
Case 
No 






1 72/F Soft tissue, 
perineum 
T4N0M1 Plasmacytoid UC, 
100% 
Cystectomy 
2 56/M Soft tissue, 
retroperitoneum 
T4N1Mx Plasmacytoid UC, 
95% 
Classical UC, 5% 
Cystectomy 
3 46/F Lymph node, 
right iliac 
T3aN2Mx Plasmacytoid UC, 
90% 
Classical UC, 10% 
Cystectomy 














Table 2. Cytologic features of plasmacytoid urothelial carcinoma 
 
Cytologic features Quantity Observed in 
number of cases 
Dyshesive single cells >50% of cells 4 
Eccentric nuclei >50% of cells 4 
Moderate nuclear variation >50% of cells 4 
Coarse nuclear chromatin >50% of cells 4 
Small or no nucleoli >50% of cells 4 
Mild irregular nuclear membrane >50% of cells 4 
Cytoplasmic vacuole < 5% 4 
Signet ring cell feature < 5% 4 
Cytoplasmic hof < 5% 4 
Binucleation < 5% 4 
Multinucleation < 5% 4 
Nucleus to cytoplasm ratio <1 >50% of cells 2 
Nucleus to cytoplasm ratio 1-3 >50% of cells 2 
 
 
